Guangyao Shao

Pharmacological analysis of Empagliflozin: Acting through the CaMKII pathway in type 2 diabetes and acute cardiovascular events

Guangyao Shao, 2022, PloS one.

LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression cancer

L. Ren, Ke Shi, F. Wang, 2019 .